Traditional Chinese medicine composite used for treating cervical spondylosis

Abstract

The invention relates to a traditional Chinese medicine composite used for treating cervical spondylosis. The composite is prepared from 225 parts of angelica, 105 parts of rhizoma ligustici wallichii, 188 parts of astragalus root, 150 parts of radix salviae miltiorrhizae, 180 parts of spatholobus stem, 300 parts of prepared rehmannia root, 105 parts of lycopodium clavatum, 180 parts of desertliving cistanche, 150 parts of rhizoma drynariae, 300 parts of mulberry twigs, 180 parts of radix puerariae and 225 parts of teasel root according to a conventional process; the composite comprises an oral liquid preparation and granules; and the research of clinical pharmacodynamical experiments proves that the invention has more obvious effect in the aspect of treating the cervical spondylosis in comparison with an original medicine composite.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating cervical spondylosis, belonging to the technical field of traditional Chinese medicine pharmacy. technical background [0002] Cervical spondylosis is a common clinical disease and frequently-occurring disease. In recent years, the incidence of cervical spondylosis has been increasing year by year, and it is said to be younger; it has seriously affected people's health. On August 26, 2009, the Chinese Patent Gazette disclosed the patent application declared by the applicant as "a Chinese patent medicine for the treatment of cervical spondylosis" and the publication number is CN101513470. The weight ratio is: Angelica 20-2300 weight units, Chuanxiong 10-1100 weight units, Astragalus 15-1900 weight units, Salvia miltiorrhiza 10-1500 weight units, Caulis Spatholobus 15-1800 weight units, Rehmannia glutinosa 20 -3,000 weight units, 10-1,100 weight units of Cistanche, 15-1,800...

AI Technical Summary

Problems solved by technology

On August 26, 2009, the Chinese Patent Gazette disclosed the patent application declared by the applicant as "a Chinese patent medicine for the treatment of cervical spondylosis" and the publication number is CN101513470. The weight ratio is: Angelica 20-2300 weight units, Chuanxiong 10-1100 weight units, Astragalus 15-1900 weight units, Salvia miltiorrhiza 10-1500 weight units, Caulis Spatholobus 15-1800 weight units, Rehmannia glutinosa 20 -3,000 weight units, 10-1,100 weight units of Cistanche, 15-1,800 weight units of Cistanche, 10-1,500 weight units of Rhizoma Drynaria, 20-3,000 weight units of Mori, 15-1,800 weight units of Pueraria , Diarrhea 20-2300 weight units, but in the actual application process we found that the effect of this Chinese patent medicine is not ideal enough

Images